Literature DB >> 29891971

Survival Comparisons Between Early Male and Female Breast Cancer Patients.

Kang Wang1, Qiu-Juan Wang2, Yong-Fu Xiong3, Yang Shi4, Wen-Jing Yang2, Xiang Zhang5, Hong-Yuan Li6.   

Abstract

We aimed to compare the overall survival (OS) and standardized mortality rate (SMR) of the male breast cancer (MBC) with female breast cancer (FBC) after propensity score matching. Based on the Surveillance, Epidemiology, and End Results (SEER), the early breast cancer patients (T1-2N0-2M0) were extracted from 1998-2007. This study included 1,111 and 2,151 patients with early MBC and FBC, respectively, whose clinicopathological characteristics were well balanced. At a mean follow-up time of 97 months, 10-year OS rate was 58.3% in the MBC group and 68.7% in the FBC (log-rank test, P < 0.001; hazard ratio (HR) = 1.45, 95% confidence interval (CI) = 1.29 to 1.64). Adjusted HR for OS between MBC and FBC were revealed from propensity score matched-multivariable Cox proportional hazards models (HR = 1.53, 95% CI = 1.35 to 1.73). Similar adjusted SMRs between MBC and FBC ((SMR = 1.98, 95% CI = 1.83,2.14) for FBC and (SMR = 2.07, 95% CI = 1.88-2.28) for MBC) were observed. The nomogram was constructed for FBC, and predicted probabilities were generally good (C-index = 0.71), whose area under curve is higher than TNM stage classification (0.74 vs 0.62). OS was significantly decreased among early MBC patients compared with FBC, but similar SMRs and its trends by age groups were observed between MBC and FBC except for young patients.

Entities:  

Mesh:

Year:  2018        PMID: 29891971      PMCID: PMC5995882          DOI: 10.1038/s41598-018-26199-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  41 in total

1.  Decline in breast cancer incidence in the United States: what about male breast cancer?

Authors:  Andreas Stang; Christoph Thomssen
Journal:  Breast Cancer Res Treat       Date:  2008-01-05       Impact factor: 4.872

2.  Male breast cancer: a population-based comparison with female breast cancer.

Authors:  William F Anderson; Ismail Jatoi; Julia Tse; Philip S Rosenberg
Journal:  J Clin Oncol       Date:  2009-12-07       Impact factor: 44.544

3.  Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?

Authors:  David Zaenger; Bryan M Rabatic; Byron Dasher; Waleed F Mourad
Journal:  Clin Breast Cancer       Date:  2015-11-17       Impact factor: 3.225

4.  Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Huaqiang Zhou; Yuanzhe Zhang; Yiyan Song; Wulin Tan; Zeting Qiu; Si Li; Qinchang Chen; Shaowei Gao
Journal:  Clin Res Hepatol Gastroenterol       Date:  2017-04-14       Impact factor: 2.947

5.  Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients.

Authors:  Holm Eggemann; Atanas Ignatov; Bobbie J Smith; Udo Altmann; Gunter von Minckwitz; Freidrich W Röhl; Mark Jahn; Serban-Dan Costa
Journal:  Breast Cancer Res Treat       Date:  2012-12-09       Impact factor: 4.872

6.  Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: A population-based study.

Authors:  José Pablo Leone; Julieta Leone; Ariel Osvaldo Zwenger; Julián Iturbe; Bernardo Amadeo Leone; Carlos Teodoro Vallejo
Journal:  Eur J Cancer       Date:  2016-12-08       Impact factor: 9.162

7.  Outcome of male breast cancer: a matched single-institution series.

Authors:  Monica Iorfida; Vincenzo Bagnardi; Nicole Rotmensz; Elisabetta Munzone; Bernardo Bonanni; Giuseppe Viale; Giancarlo Pruneri; Manuelita Mazza; Anna Cardillo; Paolo Veronesi; Alberto Luini; Viviana Galimberti; Aron Goldhirsch; Marco Colleoni
Journal:  Clin Breast Cancer       Date:  2014-03-01       Impact factor: 3.225

8.  Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983-2009.

Authors:  Jordan M Cloyd; Tina Hernandez-Boussard; Irene L Wapnir
Journal:  Ann Surg Oncol       Date:  2013-03-05       Impact factor: 5.344

9.  Male breast cancer: Modified radical mastectomy or breast conservation surgery? A case report and review of the literature.

Authors:  Gabriele Giunta; Matteo Rossi; Francesca Toia; Gaetana Rinaldi; Adriana Cordova
Journal:  Int J Surg Case Rep       Date:  2016-11-19

Review 10.  Male breast cancer: is the scenario changing.

Authors:  Kaiyumars B Contractor; Kanchan Kaur; Gabriel S Rodrigues; Dhananjay M Kulkarni; Hemant Singhal
Journal:  World J Surg Oncol       Date:  2008-06-16       Impact factor: 2.754

View more
  3 in total

1.  A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery.

Authors:  Xin Chai; Mei-Yang Sun; Hong-Yao Jia; Min Wang; Ling Cao; Zhi-Wen Li; Dun-Wei Wang
Journal:  PeerJ       Date:  2019-10-14       Impact factor: 2.984

2.  Comparison between male and female breast cancer survival using propensity score matching analysis.

Authors:  Serena Scomersi; Fabiola Giudici; Giuseppe Cacciatore; Pasquale Losurdo; Stefano Fracon; Sara Cortinovis; Rita Ceccherini; Fabrizio Zanconati; Maura Tonutti; Marina Bortul
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

3.  Clinical features and prognostic factors of male breast cancer vs. female breast cancer.

Authors:  Guo Sang; Hong Pan; Chen Lu; Rongneng Sun; Xiaoming Zha; Shui Wang; Dongya Zhu
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.